Acetylated Tubulin Is a Biomarker for Severe Depression
By LabMedica International staff writers Posted on 23 Apr 2020 |
Image: Representation of the molecular structure of tubulin protein (Photo courtesy of Wikimedia Commons)
A recent study suggested that the structural protein tubulin could serve as a novel diagnostic biomarker for severe depression.
The molecular mechanisms involved in the development of depression, which in its severest form may lead to suicide, are only poorly understood. It is known that post-translational modifications of the structural protein tubulin alter microtubule dynamics and play a role in mood disorders. Furthermore, tubulin interacts closely with G-alpha-s, the G-protein responsible for activation of adenylyl cyclase. This enzyme catalyzes the production of cAMP, a molecule necessary for quick messaging in the brain.
Investigators at the University of Illinois at Chicago (USA) examined the amount of modified (acetylated) tubulin present in the brains from people who were not depressed as well as those from people with depression who died by suicide or by other causes.
For this study, the investigators evaluated tubulin acetylation in whole tissue homogenates and in plasma-membrane and lipid-raft membrane domains in tissue from normal control (NC) subjects, depressed suicides, and depressed non-suicides (human males/females). Lipid rafts are areas within the plasma membranes of cells, which contain combinations of glycosphingolipids, cholesterol, and protein receptors organized into glycolipoprotein lipid microdomains.
Results sited in the current study tissue indicated that tissue homogenates showed no changes in tubulin acetylation between controls, depressed suicides, and depressed non-suicides. However, plasma-membrane associated tubulin showed significant decreases in acetylation from depressed-suicides and depressed-non-suicides compared to controls. No change was seen in expression of the enzymes responsible for tubulin acetylation or de-acetylation.
The investigators said that these results suggested that during depression, tubulin localized in the membrane maintained a lower acetylation state, permitting increased sequestration of G-alpha-s in lipid-raft domains, where it was less likely to couple to adenylyl cyclase for cAMP production. Imaging studies have shown that depressed individuals have less cAMP in their brains, which is remedied by successful treatment.
The study was published in the April 13, 2020, online edition of the Journal of Neuroscience.
Related Links:
University of Illinois at Chicago
The molecular mechanisms involved in the development of depression, which in its severest form may lead to suicide, are only poorly understood. It is known that post-translational modifications of the structural protein tubulin alter microtubule dynamics and play a role in mood disorders. Furthermore, tubulin interacts closely with G-alpha-s, the G-protein responsible for activation of adenylyl cyclase. This enzyme catalyzes the production of cAMP, a molecule necessary for quick messaging in the brain.
Investigators at the University of Illinois at Chicago (USA) examined the amount of modified (acetylated) tubulin present in the brains from people who were not depressed as well as those from people with depression who died by suicide or by other causes.
For this study, the investigators evaluated tubulin acetylation in whole tissue homogenates and in plasma-membrane and lipid-raft membrane domains in tissue from normal control (NC) subjects, depressed suicides, and depressed non-suicides (human males/females). Lipid rafts are areas within the plasma membranes of cells, which contain combinations of glycosphingolipids, cholesterol, and protein receptors organized into glycolipoprotein lipid microdomains.
Results sited in the current study tissue indicated that tissue homogenates showed no changes in tubulin acetylation between controls, depressed suicides, and depressed non-suicides. However, plasma-membrane associated tubulin showed significant decreases in acetylation from depressed-suicides and depressed-non-suicides compared to controls. No change was seen in expression of the enzymes responsible for tubulin acetylation or de-acetylation.
The investigators said that these results suggested that during depression, tubulin localized in the membrane maintained a lower acetylation state, permitting increased sequestration of G-alpha-s in lipid-raft domains, where it was less likely to couple to adenylyl cyclase for cAMP production. Imaging studies have shown that depressed individuals have less cAMP in their brains, which is remedied by successful treatment.
The study was published in the April 13, 2020, online edition of the Journal of Neuroscience.
Related Links:
University of Illinois at Chicago
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans